secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0001641172-25-005553
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma to present at Planet MicroCap Showcase VEGAS 2025 on April 23
----------------------------------------------------------------------------

- Presentation by Dr. Anatoly Dritschilo on April 23 at 2:30 PM PT at Planet MicroCap Showcase VEGAS 2025.
- Focus on Phase 2 trial update of Ropidoxuridine + RT for glioblastoma and Shuttle Diagnostics advancements for prostate cancer.
- Company will also conduct 1x1 meetings on April 24 at the conference.
- No financial results or material changes announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225005553/0001641172-25-005553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225005553/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer